FHTX

Foghorn Therapeutics Inc.

Healthcare · Biotechnology

$230.49 sample

+0.45 (+0.20%) 1D

Market cap

$1.27T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-21

Alerts

8

Price$230.49 -0.77% 3M daily closessample

237.02215.40

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider buy: Director
Oct 02INSInsider buy: Chief Executive Officer
Sep 25INSInsider sell: Chief Executive Officer
Sep 21SEC10-Q filed
Sep 10INSInsider buy: Chief Executive Officer
Sep 04SECForm 144 filed
Aug 28INSInsider buy: Chief Financial Officer
Aug 20INSInsider sell: Chief Financial Officer

Sign up to see the real FHTX record →

Company facts

SEC EDGAR registration

Name: Foghorn Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +60sample, -100 to +100
Reporting currency: USD

Who is positioning in FHTX

sample

Insiders: 16 insider transactions over 90 days, net selling, $887.5M
Congress: 2 members traded over 90 days
Institutions · 13F: 23 funds hold $15.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$51.0B +17.4% y/y

Q4 2024Q3 2026

Inventory$29.7B +8.9% y/y

Q4 2024Q3 2026

Accounts receivable$22.7B +7.9% y/y

Q4 2024Q3 2026

Total debt$61.2B +14.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $939.0B +13.0% 3M
Sample peer B: $592.0B -3.9% 3M
Sample peer C: $671.2B -6.7% 3M
Sample peer D: $592.5B -0.5% 3M
Sample peer E: $455.9B +9.8% 3M